Evidence map›Paper›PMID 34131632›Full record

ArticleHemaSphere2021

COVID-19 in a Post-transplant Heart Recipient Who Developed Aggressive Lymphoma: A Biphasic Course During Rituximab Treatment.

Michele Clerico, Irene Dogliotti, Andrea Calcagno, Daniele Grimaldi, Sarah Leone, Simone Ragaini, Massimo Boffini, Daniele Caracciolo, Simone Ferrero, Cristina Barbero and 6 more

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in HemaSphere, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

Michele ClericoDivision of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino, A.O.U. "Città della Salute e della Scienza di Torino", Turin, Italy.
Irene DogliottiDivision of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino, A.O.U. "Città della Salute e della Scienza di Torino", Turin, Italy.
Andrea CalcagnoUnit of Infectious Diseases, Department of Medical Sciences, University of Torino, Ospedale Amedeo di Savoia, ASL TO2, Turin, Italy.
Daniele GrimaldiDivision of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino, A.O.U. "Città della Salute e della Scienza di Torino", Turin, Italy.
Sarah LeoneDepartment of Internal Medicine, NYU Grossman School of Medicine, New York, USA.
Simone RagainiDivision of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino, A.O.U. "Città della Salute e della Scienza di Torino", Turin, Italy.
Massimo BoffiniDepartment of Cardiovascular and Thoracic Surgery, University of Torino, A.O.U. "Città della Salute e della Scienza di Torino", Turin, Italy.
Daniele CaraccioloDivision of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino, A.O.U. "Città della Salute e della Scienza di Torino", Turin, Italy.
Simone FerreroDivision of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino, A.O.U. "Città della Salute e della Scienza di Torino", Turin, Italy.
Cristina BarberoDepartment of Cardiovascular and Thoracic Surgery, University of Torino, A.O.U. "Città della Salute e della Scienza di Torino", Turin, Italy.
Elisa ZanottoUnit of Microbiology and Virology, Department of Public Health and Pediatric Sciences, University of Torino, A.O.U. "Città della Salute e della Scienza di Torino", Turin, Italy.
Giacomo StroffoliniUnit of Infectious Diseases, Department of Medical Sciences, University of Torino, Ospedale Amedeo di Savoia, ASL TO2, Turin, Italy.
Rossana CavalloUnit of Microbiology and Virology, Department of Public Health and Pediatric Sciences, University of Torino, A.O.U. "Città della Salute e della Scienza di Torino", Turin, Italy.
Mauro RinaldiDepartment of Cardiovascular and Thoracic Surgery, University of Torino, A.O.U. "Città della Salute e della Scienza di Torino", Turin, Italy.
Benedetto BrunoDivision of Hematology and Medical Oncology, NYU Grossman School of Medicine, Perlmutter Cancer Center, NYU Langone Health, New York, USA.
Federica CavalloDivision of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino, A.O.U. "Città della Salute e della Scienza di Torino", Turin, Italy.
University of Turin · ITAzienda Ospedaliera Citta' della Salute e della Scienza di Torino · ITOspedale Amedeo di Savoia · ITNew York University · USNYU Langone Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34131632
PMCPMC8196101
OpenAlexW3168341472

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.